The use of cilostazol for secondary stroke prevention: isn't time to be evaluated in Western countries?

Expert Opin Pharmacother. 2020 Mar;21(4):381-387. doi: 10.1080/14656566.2019.1707181. Epub 2020 Jan 14.
No abstract available

Keywords: Cilostazol; ethnicity based dosing; phosphodiesterase; polymorphism; stroke.

Publication types

  • Editorial